Voyager Therapeutics Inc (VYGR)
7.31
-0.26
(-3.43%)
USD |
NASDAQ |
Apr 25, 10:32
Voyager Therapeutics Price to Book Value: 1.680 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 1.739 |
| April 23, 2024 | 1.758 |
| April 22, 2024 | 1.739 |
| April 19, 2024 | 1.723 |
| April 18, 2024 | 1.735 |
| April 17, 2024 | 1.778 |
| April 16, 2024 | 1.834 |
| April 15, 2024 | 1.893 |
| April 12, 2024 | 1.937 |
| April 11, 2024 | 2.017 |
| April 10, 2024 | 2.029 |
| April 09, 2024 | 2.089 |
| April 08, 2024 | 2.082 |
| April 05, 2024 | 2.144 |
| April 04, 2024 | 2.098 |
| April 03, 2024 | 2.148 |
| April 02, 2024 | 2.277 |
| April 01, 2024 | 2.422 |
| March 28, 2024 | 2.139 |
| March 27, 2024 | 2.197 |
| March 26, 2024 | 2.302 |
| March 25, 2024 | 2.128 |
| March 22, 2024 | 2.070 |
| March 21, 2024 | 2.160 |
| March 20, 2024 | 2.378 |
| Date | Value |
|---|---|
| March 19, 2024 | 2.312 |
| March 18, 2024 | 2.089 |
| March 15, 2024 | 2.132 |
| March 14, 2024 | 2.098 |
| March 13, 2024 | 2.100 |
| March 12, 2024 | 2.089 |
| March 11, 2024 | 2.082 |
| March 08, 2024 | 2.153 |
| March 07, 2024 | 2.169 |
| March 06, 2024 | 2.121 |
| March 05, 2024 | 2.091 |
| March 04, 2024 | 2.215 |
| March 01, 2024 | 2.169 |
| February 29, 2024 | 1.912 |
| February 28, 2024 | 2.061 |
| February 27, 2024 | 2.047 |
| February 26, 2024 | 1.985 |
| February 23, 2024 | 1.880 |
| February 22, 2024 | 1.772 |
| February 21, 2024 | 1.756 |
| February 20, 2024 | 1.781 |
| February 16, 2024 | 1.776 |
| February 15, 2024 | 1.809 |
| February 14, 2024 | 1.734 |
| February 13, 2024 | 1.682 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9438
Minimum
Sep 29 2021
10.20
Maximum
Jun 18 2019
3.338
Average
2.543
Median
Price to Book Value Benchmarks
| Biogen Inc | 1.961 |
| United Therapeutics Corp | 1.850 |
| MEI Pharma Inc | 0.3651 |
| Macrogenics Inc | 6.108 |
| Moderna Inc | 2.918 |
Price to Book Value Related Metrics
| PE Ratio | 2.413 |
| PS Ratio | 1.316 |
| Price to Free Cash Flow | 4.406 |
| Price | 7.31 |
| Earnings Yield | 41.45% |
| Market Cap | 396.94M |
| Operating PE Ratio | 2.696 |
| Normalized PE Ratio | 2.413 |